Skip to main content
Erschienen in: Lung 1/2015

01.02.2015

Physical Activity and the Frequency of Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease

verfasst von: M. Schönmann, N. A. Sievi, C. F. Clarenbach, T. Brack, M. Brutsche, M. Frey, S. Irani, J. D. Leuppi, J. Ruediger, O. Senn, R. Thurnheer, M. Kohler

Erschienen in: Lung | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acute exacerbations (AE) in patients with COPD are associated with a decline in lung function, increased risk of hospitalization, and mortality. In this cross-sectional study we tested whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Methods

In 210 patients with COPD (67 % men; mean (SD) age: 63 (8) years) enrolled in The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOPDOCS) physical activity (PA) (steps per day, physical activity level, (PAL)), exercise capacity (6-min walking distance, (6MWD)), comorbidities, lung function, and medication were assessed. Differences between COPD patients with frequent (≥2 year) and infrequent (0–1 year) exacerbations were assessed. Univariate and multivariate analyses were performed to investigate whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Results

Patients with frequent AE had a significantly lower FEV1 and 6MWD compared to patients with infrequent AE. In univariate analysis, the number of exacerbations was inversely associated with FEV1, 6MWD, BMI, and smoking status while there was a positive association with RV/TLC and combined inhaled medication. However, there was no significant association with PAL and steps per day. In multivariate analysis, FEV1 and the use of combined inhaled medication were independently associated with the number of AE, after correction for covariates.

Conclusions

The findings of this study imply that FEV1, independent of inhaled medication, is significantly associated with COPD exacerbations. Neither physical activity nor exercise capacity was independently associated with COPD exacerbations.
Literatur
2.
Zurück zum Zitat Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef
3.
Zurück zum Zitat Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138PubMedCrossRef Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138PubMedCrossRef
4.
Zurück zum Zitat Anzueto A, Leimer I, Kesten S (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chronic Obstr Pulm Dis 4:245–251 Anzueto A, Leimer I, Kesten S (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chronic Obstr Pulm Dis 4:245–251
5.
Zurück zum Zitat Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164(3):358–364PubMedCrossRef Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164(3):358–364PubMedCrossRef
6.
Zurück zum Zitat Cote CG, Dordelly LJ, Celli BR (2007) Impact of COPD exacerbations on patient-centered outcomes. Chest 131(3):696–704PubMedCrossRef Cote CG, Dordelly LJ, Celli BR (2007) Impact of COPD exacerbations on patient-centered outcomes. Chest 131(3):696–704PubMedCrossRef
7.
Zurück zum Zitat Vestbo J, Edwards LD, Scanlon PD et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184–1192PubMedCrossRef Vestbo J, Edwards LD, Scanlon PD et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184–1192PubMedCrossRef
8.
Zurück zum Zitat Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122PubMedCentralPubMed Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122PubMedCentralPubMed
9.
Zurück zum Zitat Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422PubMedCrossRef Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422PubMedCrossRef
10.
Zurück zum Zitat Connors AF Jr., Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 154(4 Pt 1):67–959 Connors AF Jr., Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 154(4 Pt 1):67–959
11.
Zurück zum Zitat Gunen H, Hacievliyagil SS, Kosar F et al (2005) Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26(2):234–241PubMedCrossRef Gunen H, Hacievliyagil SS, Kosar F et al (2005) Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26(2):234–241PubMedCrossRef
12.
Zurück zum Zitat Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931PubMedCentralPubMedCrossRef Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Garcia-Rio F, Rojo B, Casitas R et al (2012) Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 142(2):338–346PubMedCrossRef Garcia-Rio F, Rojo B, Casitas R et al (2012) Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 142(2):338–346PubMedCrossRef
14.
Zurück zum Zitat Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778PubMedCentralPubMedCrossRef Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Garcia-Aymerich J, Serra I, Gomez FP et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70PubMedCrossRef Garcia-Aymerich J, Serra I, Gomez FP et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70PubMedCrossRef
16.
Zurück zum Zitat Casaburi R (2011) Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 8(4):334–337PubMedCrossRef Casaburi R (2011) Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 8(4):334–337PubMedCrossRef
17.
Zurück zum Zitat Garcia-Aymerich J, Farrero E, Felez MA et al (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105PubMedCentralPubMedCrossRef Garcia-Aymerich J, Farrero E, Felez MA et al (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Seidel D, Cheung A, Suh ES et al (2012) Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16(8):1015–1019PubMedCrossRef Seidel D, Cheung A, Suh ES et al (2012) Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16(8):1015–1019PubMedCrossRef
19.
Zurück zum Zitat Donaldson GC, Wilkinson TM, Hurst JR et al (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(5):446–452PubMedCrossRef Donaldson GC, Wilkinson TM, Hurst JR et al (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(5):446–452PubMedCrossRef
20.
Zurück zum Zitat Lichtman SW, Pisarska K, Berman ER et al (1992) Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 327(27):1893–1898PubMedCrossRef Lichtman SW, Pisarska K, Berman ER et al (1992) Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 327(27):1893–1898PubMedCrossRef
21.
Zurück zum Zitat van Gestel AJ, Clarenbach CF, Stowhas AC et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 7(11):e48081PubMedCentralPubMedCrossRef van Gestel AJ, Clarenbach CF, Stowhas AC et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 7(11):e48081PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Waschki B, Spruit MA, Watz H et al (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106(4):522–530PubMedCrossRef Waschki B, Spruit MA, Watz H et al (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106(4):522–530PubMedCrossRef
23.
Zurück zum Zitat Manini TM, Everhart JE, Patel KV et al (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296(2):171–179PubMedCrossRef Manini TM, Everhart JE, Patel KV et al (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296(2):171–179PubMedCrossRef
24.
Zurück zum Zitat Scheers T, Philippaerts R, Lefevre J (2012) Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear armband complemented with an electronic diary. Int J Behav Nutr Phys Act 9(1):71PubMedCentralPubMedCrossRef Scheers T, Philippaerts R, Lefevre J (2012) Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear armband complemented with an electronic diary. Int J Behav Nutr Phys Act 9(1):71PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat ATS (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef ATS (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef
26.
Zurück zum Zitat Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241PubMedCrossRef Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241PubMedCrossRef
27.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338PubMedCrossRef
28.
Zurück zum Zitat Boon RM, Hamlin MJ, Steel GD et al (2010) Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry. Br J Sports Med 44(10):741–746PubMedCrossRef Boon RM, Hamlin MJ, Steel GD et al (2010) Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry. Br J Sports Med 44(10):741–746PubMedCrossRef
29.
Zurück zum Zitat Ekelund U, Sepp H, Brage S et al (2006) Criterion-related validity of the last 7-day, short form of the international physical activity questionnaire in Swedish adults. Public Health Nutr 9(2):258–265PubMedCrossRef Ekelund U, Sepp H, Brage S et al (2006) Criterion-related validity of the last 7-day, short form of the international physical activity questionnaire in Swedish adults. Public Health Nutr 9(2):258–265PubMedCrossRef
30.
Zurück zum Zitat Watz H, Waschki B, Meyer T et al (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272PubMedCrossRef Watz H, Waschki B, Meyer T et al (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272PubMedCrossRef
31.
Zurück zum Zitat Carr SJ, Goldstein RS, Brooks D (2007) Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132(1):127–134PubMedCrossRef Carr SJ, Goldstein RS, Brooks D (2007) Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132(1):127–134PubMedCrossRef
32.
Zurück zum Zitat McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedCentralPubMedCrossRef McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434–2439PubMedCrossRef Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434–2439PubMedCrossRef
Metadaten
Titel
Physical Activity and the Frequency of Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
verfasst von
M. Schönmann
N. A. Sievi
C. F. Clarenbach
T. Brack
M. Brutsche
M. Frey
S. Irani
J. D. Leuppi
J. Ruediger
O. Senn
R. Thurnheer
M. Kohler
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Lung / Ausgabe 1/2015
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9673-7

Weitere Artikel der Ausgabe 1/2015

Lung 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.